Literature DB >> 7626224

Protection against Mycoplasma pulmonis infection by genetic vaccination.

W C Lai1, M Bennett, S A Johnston, M A Barry, S P Pakes.   

Abstract

The induction of an immune response against a foreign protein usually requires purification of that protein, which is injected into animals. The isolation of pure protein is time consuming and costly. Recently, a technique called biolistic transformation (biological ballistic system) microparticle injection, gene gun, or particle bombardment was developed. The basic idea is that DNA or biological material coated onto heavy tungsten or gold particles is shot into target cells or animals. We have vaccinated mice by introducing the gene (Mycoplasma pulmonis DNA or a specific fragment) encoding a protein recognized by a protective monoclonal antibody directly into the skin or muscle of mice by two methods: (i) using a hand-held form of the biolistic system that can propel DNA-coated gold microprojectiles (2 micrograms of DNA) directly into the skin; (ii) using a conventional intramuscular injection of the DNA (100 micrograms) into quadricep muscles of transfected mice. HeLa cells were transfected in vitro by the gene gun or by the liposomal delivery system. Indirect immuno-fluorescent antibody (IFA) assay of culture cells indicated that both methods could be successful. Production of antibody and cell-mediated immunity against M.pulmonis were monitored by assaying serum IFA and enzyme-linked immunosorbent assay (ELISA), and delayed type hypersensitivity. In addition, macrophage migration inhibition and lymphocyte transformation to antigen in spleen cells were also tested. Both delivery systems induced humoral and cellular immunity, and vaccinated the mice against infection. Genetic immunization by using the gene gun saves time, money, and labor; moreover, this general method is also applicable to gene therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626224     DOI: 10.1089/dna.1995.14.643

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  8 in total

Review 1.  Drug delivery issues in vaccine development.

Authors:  M F Powell
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

Review 2.  DNA vaccines for targeting bacterial infections.

Authors:  Mariana Ingolotti; Omkar Kawalekar; Devon J Shedlock; Karuppiah Muthumani; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

3.  Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells.

Authors:  E Martin; A T Kamath; J A Triccas; W J Britton
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

4.  DNA vaccines encoding viral glycoproteins induce nonspecific immunity and Mx protein synthesis in fish.

Authors:  C H Kim; M C Johnson; J D Drennan; B E Simon; E Thomann; J A Leong
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 5.  DNA vaccines for emerging infectious diseases: what if?

Authors:  R G Whalen
Journal:  Emerg Infect Dis       Date:  1996 Jul-Sep       Impact factor: 6.883

6.  Coexpression of 16.8 kDa antigen of Mycobacterium avium paratuberculosis and murine gamma interferon in a bicistronic vector and studies on its potential as DNA vaccine.

Authors:  Megha Kadam; Salunkhe Shardul; J L Bhagath; Vinita Tiwari; N Prasad; P P Goswami
Journal:  Vet Res Commun       Date:  2009-02-06       Impact factor: 2.459

Review 7.  Genomics and bacterial pathogenesis.

Authors:  G M Weinstock
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

8.  Protective effect of the DNA vaccine encoding the major house dust mite allergens on allergic inflammation in the murine model of house dust mite allergy.

Authors:  Nacksung Kim; Soon Seog Kwon; Jaechun Lee; Sohyung Kim; Tai June Yoo
Journal:  Clin Mol Allergy       Date:  2006-02-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.